| Entry |
|
|---|
| Name |
Sofosbuvir - velpatasvir - voxilaprevir mixt;
Vosevi (TN)
|
|---|
| Product |
|
|---|
| Component |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiviral |
|---|
| Disease |
Chronic hepatitis C virus infection [DS: H00413] |
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AP Antivirals for treatment of HCV infections
J05AP56 Sofosbuvir, velpatasvir and voxilaprevir
D10900 Sofosbuvir - velpatasvir - voxilaprevir mixt <US>
Antiinfectives [br08350.html]
Antivirals
D10900
New drug approvals in the USA [br08319.html]
New Molecular Entity and New Therapeutic Biological Product Approvals
D10900
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10900
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10900
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
